The first notable difference was seen in all-cause mortality in the emulation of the semaglutide trials, which differed from the trial report
Presently, there are numerous FDA accepted circumstances for the practice of HBOT in clinical toxicology as carbon monoxide poisoning, as well as gas and air embolism, clostridial myositis, crush injury, compartment syndrome, decompression sickness, diabetic foot, and chronic intractable osteomyelitis [33]
Novo Nordisk on Tuesday asked the Food and Drug Administration to prevent compounding pharmacies from making unapproved and often cheaper versions of its popular weight loss injection Wegovy and diabetes treatment Ozempic, arguing that the medications are too complex for those manufacturers to make safely
And frankly, we already do similar interventions, and we pay for similar interventions to the current model that we have that are high costs, with long term effects, with limited knowledge of what the long term impact is, and theyre high risk, and its for small patient populations
